Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bial Aristegui

M&A STATUS
91-100 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Manufacturer and seller of pharmaceutical products created to provide a complete therapeutic service for allergic immunotherapy. The company's pharmaceutical products are comprised of vaccines used for the treatment of allergic diseases and diagnostic tests enabling customers avail a complete product portfolio of immunotherapy products both in the form of injections (SCIT) as by means of administering drops under the tongue (SLIT).

Formerly Known As
Aristegui
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Roxall Medizin
Primary Office
  • Calle Clara del Rey nº 31, 1º planta
  • 28002 Madrid
  • Spain

Bial Aristegui Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bial Aristegui‘s full profile, request access.

Request full access to PitchBook

Bial Aristegui Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bial Aristegui‘s full profile, request access.

Request full access to PitchBook